Skip to content
Screener

Milestone Pharmaceuticals MIST Q4 2025 Annual earnings

Reported March 20, 2026 · Before market open

Revenue$1.5MMiss by $36.0M
EPS-$0.16Beat by $0.02
Revenue estimate$37.5M
EPS estimate-$0.18

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$1.1M
EPS estimate-$0.20

FAQ

When did Milestone Pharmaceuticals report Q4 2025 earnings?
Milestone Pharmaceuticals (MIST) reported Q4 2025 earnings on March 20, 2026 before market open.
What were Milestone Pharmaceuticals's Q4 2025 revenue and EPS?
Milestone Pharmaceuticals reported revenue of $1.5M and eps of $-0.16 for Q4 2025.
Did Milestone Pharmaceuticals beat estimates in Q4 2025?
Revenue missed the consensus estimate of $37.5M by $36.0M. EPS beat the consensus estimate of $-0.18 by $0.02.
How did Milestone Pharmaceuticals's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 15.8% from $-0.19.
Where can I find Milestone Pharmaceuticals's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-032427) and the 10-K periodic report (0001104659-26-032415) directly on SEC EDGAR. The filing index links above go to sec.gov.